These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6388549)

  • 1. Use of an intravenous sodium load in screening for primary hyperaldosteronism.
    Stokes GS; Monaghan JC; Mennie BA
    Aust N Z J Med; 1984 Jun; 14(3):201-7. PubMed ID: 6388549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOCA test for aldosteronism: its usefulness and implications.
    Rodríguez JA; Lopez JM; Biglieri EG
    Hypertension; 1981; 3(6 Pt 2):II-102-6. PubMed ID: 7028610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypokalemia, a key clinical data for diagnosing primary hyperaldosteronism].
    Rodríguez Maya B; Rodríguez Goncer I; Diego Hernández C
    Hipertens Riesgo Vasc; 2016; 33(2):69-73. PubMed ID: 26869044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for primary aldosteronism: hypokalemia in hypertensive patients.
    Goldenberg K; Snyder DK
    J Gen Intern Med; 1986; 1(6):368-72. PubMed ID: 3540235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary aldosteronism: management issues.
    Young WF
    Ann N Y Acad Sci; 2002 Sep; 970():61-76. PubMed ID: 12381542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary aldosteronism: A common and curable form of hypertension.
    Young WF
    Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hydronephrosis complicated with primary aldosteronism: a case report and review of the literature.
    Sun J; Zeng Q; Lai L; Gu M; Liu D; Wu G; Peng C; Yang S; Li Q; Lu J
    J Med Case Rep; 2024 Oct; 18(1):463. PubMed ID: 39369228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary aldosteronism].
    Amar L
    Rev Prat; 2015 Jun; 65(6):817-21. PubMed ID: 26298907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of primary hyperaldosteronism.
    Blumenfeld JD; Sealey JE; Schlussel Y; Vaughan ED; Sos TA; Atlas SA; Müller FB; Acevedo R; Ulick S; Laragh JH
    Ann Intern Med; 1994 Dec; 121(11):877-85. PubMed ID: 7978702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
    Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
    Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
    Zadik Z; Levin PA; Hamilton BP; Kowarski AA
    Hypertension; 1986 Apr; 8(4):285-9. PubMed ID: 3514448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary hyperaldosteronism and adrenal tumors. Clinico-surgical experience with 9 patients].
    Bortolotto LA; Silva HB; Lopes HF; Jatene F; Jatene A; Pileggi F
    Arq Bras Cardiol; 1994 Mar; 62(3):165-9. PubMed ID: 7980077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.
    Nakada T; Furuta H; Katayama T; Sumiya H; Shimazaki J
    J Urol; 1989 Jul; 142(1):13-8. PubMed ID: 2525199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
    Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
    Young WF
    Endocrinology; 2003 Jun; 144(6):2208-13. PubMed ID: 12746276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.